South Africa's Aspen Pharmacare buys drugs business of Australia's Sigma.

By bne IntelliNews January 17, 2011
Aspen Pharmacare, South Africa's leading pharmaceutical company, said that all conditions have been met for it to acquire the pharmaceutical business of Australian-based Sigma Pharmaceuticals for ZAR 6.14bn (USD 886.5mn). The acquisition was approved following the extraordinary meeting of Sigma shareholders held on January 14, the buyer said in a statement. The effective date of change of ownership is January 31 and will position Aspen as the leading pharmaceutical company in Australia by volume of scripts generated. Sigma's pharmaceutical business consists of an extensive product portfolio of branded, generic and OTC products as well as five manufacturing facilities. Sigma will retain its wholesale business. Based upon the historic performance of Aspen and Sigma in the Australian market, the combination of Sigma's pharmaceutical business with Aspen's existing business in Australia should lead to one in every eight Australian prescriptions being written for an Aspen product and result in Aspen being ranked first by volume of scripts generated in Australia.

Related Articles

South Africas Exxaro mulls firing striking coal miners.

South African company Exxaro Resources said one of the options it currently considers is dismissing striking coal mine workers who fail to return to work in the week of March 25, fin24 reported ... more

South Africas Telkom says there is no decision to lay off 13,000 employees.

South Africas telecommunication operator Telkom said that it has not made a decision on retrenching 13,000 employees, or more than half of its staff, TechCentral reported quoting a company ... more

BP, Masana Petroleum Solutions sell LPG business in South Africa.

Oryx Energies, a major independent provider of oil and gas products and services in Africa, has agreed to buy the South African liquefied petroleum gas (LPG) distribution businesses of BP and ... more

Dismiss